Related Experiment Video
Updated: Jul 12, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
[Multiple sclerosis and Epstein-Barr virus : new developments and perspectives]
1Institut für Virologie, Haus 47, Universitätsklinikum des Saarlandes, 66421, Homburg/Saar, Deutschland. klemens.ruprecht@uniklinikum-saarland.de
Abstract:
Data from studies of twins and migrants with multiple sclerosis (MS) imply environmental factors in the development of MS. In this respect, increasing evidence indicates that Epstein-Barr virus (EBV) plays a unique role as an infectious risk factor for MS. A nearly 100% seroprevalence of antibodies to EBV in patients with MS, elevated EBV antibody titers years before clinical onset of the disease, and an increased risk for MS after symptomatic primary EBV infection (infectious mononucleosis) suggest an association of MS with a previous infection with EBV. However, the precise mechanisms through which EBV may contribute to MS are still unclear. Currently discussed potential mechanisms are outlined. The notion of a persisting (possibly immunological) change caused during the acute phase of primary EBV infection and subsequently leading to permanently elevated MS risk appears compatible with several aspects of the association found between MS and EBV.
Insights
Environmental factors contribute to multiple sclerosis (MS). The Epstein-Barr virus (EBV) is increasingly implicated as an infectious risk factor, with infection potentially leading to a permanently elevated MS risk.
Area of Science:
- Neurology
- Virology
- Immunology
Context:
- Studies of twins and migrants suggest environmental factors in multiple sclerosis (MS) development.
- Growing evidence points to Epstein-Barr virus (EBV) as a significant infectious risk factor for MS.
Purpose:
- To explore the association between Epstein-Barr virus (EBV) and multiple sclerosis (MS).
- To outline potential mechanisms by which EBV may contribute to MS pathogenesis.
Summary:
- High seroprevalence of EBV antibodies in MS patients and elevated titers preceding disease onset suggest a link.
- Increased MS risk following symptomatic primary EBV infection (infectious mononucleosis) further supports this association.
- The precise mechanisms remain unclear, but a persistent change post-EBV infection is a leading hypothesis.
Impact:
- Understanding the EBV-MS connection may reveal novel therapeutic targets for MS prevention or treatment.
- This research highlights the critical role of infectious agents in neurodegenerative diseases.
- Further investigation into EBV's role could elucidate the environmental triggers for MS.
More Related Videos
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Multiple Sclerosis l: Introduction
Encephalitis ll: Pathophysiology
Cytomegalovirus Disease
Encephalitis l: Introduction
Arboviral Encephalitis